Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension trial of SIAC plus mealtime insulin aspart versus insulin detemir plus mealtime insulin aspart in type 1 diabetes
2009-013412-13Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Oct 2009
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial in diabetes mellitus type 1 (T1D) comparing SIAC plus mealtime insulin aspart with Insulin detemir plus mealtime insulin aspart (2 arms). Primary endpoint: Treatment-emergent adverse events. Started Oct 2009; status: completed.
02
Drugs
insulin degludec + insulin aspartinsulin detemirinsulin aspart
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2009-013412-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013412-13.